The Ophthalmologist

Business & Profession Health Economics and Policy

Lighting the Way

01/31/2024 | Alun Evans | 8 min read

Sitting Down With… Geoffrey Wabulembo, Medical Director, Eye Health and NTDs at Light for the World

Subspecialties Cataract

Contrast Sensitivity: Adding SPARCS to Your Testing

01/30/2024 | Parul Ichhpujani | 5 min read

Why the Spaeth Richman Contrast Sensitivity test is set to raise the standard of CS assessments

Business & Profession Cataract

Proper Dropper

01/26/2024 | Jason Bacharach | 6 min read

Many practitioners overlook the power of coaching when it comes to the actual mechanics of drop instillation

Subspecialties Glaucoma

Advancing Glaucoma Care with Personalized Medicine

01/24/2024 | Rishikesh Gandhewar | 5 min read

Realizing the potential of precision glaucoma therapy means understanding the foundational pillars of personalized medicine

Subspecialties Retina

Izervay for GA: More to See

01/23/2024 | Julian Upton | 4 min read

Iveric Bio’s Erin Henry talks about the potential for the recently-FDA approved Izervay to address unmet needs in geographic atrophy patients

Business & Profession Practice Management

Sights for Sore Eyes

01/22/2024 | Malini Gupta | 4 min read

How Malini Gupta uses art to highlight the impact of endocrine disrupting chemicals (EDCs) on ocular health

Subspecialties Cornea / Ocular Surface

Embracing Drop-Free Treatment

01/19/2024 | Nicole Fram | 4 min read

Nicole Fram discusses whether the future of ophthalmology will ever be drop-free

Subspecialties Cornea / Ocular Surface

Opening a Window into Brain Trauma

01/17/2024 | Georgia Hulme, Jessica Allerton, Alun Evans | 5 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Business & Profession Imaging & Diagnostics

The Cerebral Window

01/16/2024 | Kai Jin, Andrzej Grzybowski | 5 min read

Examining the retina’s vital role in diagnosing CNS disorders

Subspecialties Retina

At First Sight: The Future of Gene Therapy for Retinal Health

01/15/2024 | Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Subspecialties Basic & Translational Research